Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Microbiology Market Research Report

  • Report Code: MI 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Global microbiology market is growing due to increase in prevalence of pathogenic diseases, growth in discovery of mutating and adapting bacterium, and the growing need for speedy microbiological testing methods.

 

In 2013, the microbiology testing market accounted for 5% in the global IVD market and contributed $3556.7 million in 2013 to the IVD market, and is estimated to reach $4737.2 million by 2018, at a CAGR of 6.2% from 2013 to 2018.

 

The clinical microbiology laboratory has a whole array of diagnostics instruments used for serology, virus culture, and blood culture. This method is used for the detection of influenza viruses as well as a number of other diseases. Clinical microbiology testing is indispensable for identifying bacterial, fungal, and parasitic infections as well as for preventing epidemics. It also helps in the clinical management of patients. The rapid diagnostic testing market is the most sought after in the microbiology industry as it provides results in less than 30 minutes. Thus, a faster turnaround time (TAT) and immediate results are the major factors that will drive the microbiology market.

 

There has been an increase in the number of infectious diseases across the globe. The factors such as the rise in incidence of HIV and tuberculosis as well as sexually transmitted diseases in developing countries along with the rise in respiratory diseases like influenza in developed countries like Europe and America will drive the microbiology market.

 

Technological advances, like automated instruments for identification of pathogens in laboratories, have been of immense help to microbiologists. Automation has helped to enhance key laboratory performance attributes like consistency, quality, and a slower total turnaround time. Thus, automation is the new trend in the microbiology field. However, it will take time to pick-up as it requires extensive training of laboratory personnel. These machines are helping medical practitioners receive accurate data and determine the precise course of treatment without spending too much time.

 

Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the market. The emerging countries are expected to outperform the U.S. and European countries. This is mainly due to the increase in the major hospital chains opening new centers in major cities as well as an increase in the government expenditure.

 

The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.

 

The report ‘Global Microbiology Market forecast for 2018’ analyzes the market by segments such as instruments and reagents. These two segments experienced a positive growth till 2013, with a market value of $3.55 billion, comprising of $2.99 billion for reagents and $0.55 billion for instruments. It is expected to grow at a CAGR of 6.2%.

 

The Americas commanded the largest share of 42% in the global microbiology market at $1485.02 million in 2013, and is expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

 

The U.S. commanded the largest share of 89% in the American microbiology IVD market at $1320.4 million in 2012, and is expected to reach $1715.6 million by 2017, at a CAGR of 5.6% from 2013 to 2018.

 

Europe holds the second-largest market position. Germany commanded the largest share of 20% at $223.7 million in 2013, and is expected to reach $272.5 million by 2018, at a CAGR of 4.2% from 2013 to 2018.

 

China commanded the largest share of 53% at $177.1 million in 2013 in the Asian microbiology market, and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The leading players in the microbiology market are bioMerieux SA (France), Becton Dickinson and company (U.S.), and Siemens (Germany). Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

 

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

 

Opportunity Analysis

  • Unmet needs, revenue pockets, and potential areas for expansion

 

Supplier Evaluation

  • Comprehensive review of key suppliers of analyzers, POC, and slide and imaging manufacturers

 

Extensive Market Data

  • Number of hospitals, public health laboratories, private laboratories, and blood banks

 

Current and Emerging Products

  • Analysis of current and emerging microbiology and immunodiagnostic tests
  • Review of current instrumentation technologies

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment wise and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Alternative Products: Impact analysis

 

MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).



1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology

 

2 Executive Summary
 

3 Market Overview
 

4 By Technologies
4.1 Molecular Diagnostics

 

5 By Products
5.1 Instruments
5.2 Reagents
5.3 Services & Software

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Microbiology Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Europe Microbiology Europe Microbiology
Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $223.7 million in 2013 and is expected to reach $272.5 million by 2018, at a CAGR of 4.2% from 2013 to 2018. The report “European Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents.
Upcoming
Asia Microbiology Asia Microbiology
Asian Microbiology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018. The report “Asian Microbiology Market forecast for 2018 “analyzes the market by two segments such as microbiology instruments and microbiology reagents.
Upcoming
North America Microbiology North America Microbiology
The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018. The report “North American Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents.
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539